Atelectasis medical therapy

Jump to: navigation, search

Atelectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atelectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Atelectasis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atelectasis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atelectasis medical therapy

CDC on Atelectasis medical therapy

Atelectasis medical therapy in the news

Blogs on Atelectasis medical therapy</small>

Directions to Hospitals Treating Atelectasis

Risk calculators and risk factors for Atelectasis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview

The primary treatment for atelectasis is management of the underlying cause. Besides this, supportive therapy for atelectasis includes chest physiotherapy, breathing and coughing exercises, early ambulation, nasotracheal suctioning, humidifiers, nebulized bronchodilators and supplemental oxygen in order to maintain an arterial oxygen saturation of greater than 90 percent. Intubation, mechanical support, positive pressure ventilation and continous positive airway pressure (CPAP) help in the prevention of alveolar collapse, thereby assisting in lung inflation in patients with atelectasis.

Medical Therapy

Treatment of atelectasis primarily involves treatment of the underlying cause. Besides this, supportive therapy may be given to patients.

Treatment based on cause of atelectasis

References

  1. Mironov AV, Pinchuk TP, Selina IE, Kosolapov DA (2013). "[Emergency fiberoptic bronchoscopy for diagnostics and treatment of lung atelectasis]". Anesteziol Reanimatol (in Russian) (6): 51–4. PMID 24749266. 
  2. McCool FD, Rosen MJ (January 2006). "Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines". Chest. 129 (1 Suppl): 250S–259S. PMID 16428718. doi:10.1378/chest.129.1_suppl.250S. 
  3. Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ (August 2005). "DNase and atelectasis in non-cystic fibrosis pediatric patients". Crit Care. 9 (4): R351–6. PMC 1269442Freely accessible. PMID 16137347. doi:10.1186/cc3544. 

Linked-in.jpg